Maximum Fidelity Surgical Simulations Completes Seed Funding Round
2024年7月9日 - 10:05PM
ビジネスワイヤ(英語)
Investors St. Louis Arch Angels, BioGenerator
Ventures and Missouri Technology Corporation support MaxFi’s
disruptive technology revolutionizing medical training with
lifelike cadaver simulations
Maximum Fidelity Surgical Simulations (MaxFi), which provides
lifelike cadavers to create highly realistic surgical simulations
for medical education, research and product development, and
military training, has completed its seed funding round. Led by
investors St. Louis Arch Angels, BioGenerator Ventures and Missouri
Technology Corporation (MTC), the initial seed funding round raised
$2.25 million.
“The learning experiences MaxFi provides that empower medical
professionals to optimize patient outcomes and inventors to
innovate safely and efficiently drove our decision to invest,” said
St. Louis Arch Angels President Brian Kinman. “We are confident
MaxFi will grow into a substantial business that will advance St.
Louis’ reputation as a leader in healthcare.”
“BioGenerator invested in MaxFi because we believe their unique
surgical simulation services have demonstrated strong market
demand, bolstered by a proven leadership team and a clearly
articulated operational plan,” said BioGenerator Managing Director
Crystal Winkeler.
“MTC is excited to add MaxFi to our IDEA Fund portfolio after
closing an investment in the company from our IDEA Fund through the
Seed Capital Program,” said MTC Executive Director Jack Scatizzi.
“MTC is committed to supporting early-stage high-growth potential
companies with equity-based funding through our state-sponsored
venture capital program in alignment with our mission of catalyzing
innovation and entrepreneurship for an economic development impact
in Missouri.”
Founded by Joss Fernandez, MD, FACS in 2014 in Columbia,
Missouri, MaxFi is revolutionizing surgical simulation with its
patented and proprietary cadaver perfusion system that makes
cadavers bleed, breathe and handle like live patients. Healthcare
professionals and military medical personnel rely on MaxFi surgical
simulations to gain realistic operating room and trauma care
experience. Medical device manufacturers also partner with MaxFi to
safely and cost effectively conduct research and test new products
in a lifelike environment. Current customers include Johnson &
Johnson, Washington University in St. Louis, and Safeguard
Medical.
“The completion of this seed funding round is a significant
milestone that validates our efforts and vision and marks a crucial
step toward commercialization,” Dr. Fernandez said. “We believe we
have developed a viable, sustainable and accurate solution to meet
the pressing need for realistic training for physicians, military
personnel and medical device developers.”
The capital raised will be used to build a leading-edge medical
device development and surgical simulation center in St. Louis.
Equipped with state-of-the-art labs, meeting spaces, lecture rooms
and more, the center will be the only one in the world focused on
providing lifelike cadavers to ensure clients experience the most
realistic surgical scenarios. The funds will also support the
addition of full-time employees, the development and launch of new
technology, and expansion to new markets.
“We are grateful for our investors, who are enabling us to meet
the increasing demand for our simulations and scale our operations
to new heights,” said MaxFi CEO Bob Mills. “Most importantly, they
are supporting our efforts to make discoveries that save lives and
move the practice of medicine forward.”
About Maximum Fidelity Surgical Simulations
Maximum Fidelity Surgical Simulations (MaxFi) is revolutionizing
surgical simulation by offering perfused cadavers that deliver
unparalleled realism, precisely simulating physiological conditions
such as heartbeat, blood pressure and the ability to replicate
bleeding and clotting scenarios. MaxFi's technology ensures a
highly realistic experience, empowering researchers, educators and
medical device companies to enhance patient care and innovate new
medical devices. For more information visit max-fi.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240709167034/en/
Maggie Teson Common Ground Public Relations 636-530-1235, ext.
223 maggiet@commongroundpr.com